Stock Detail
SINOVAC BIOTECH LTD - ORDINARY SHARES (ANTIGUA/BARBUDO)
Biotechnology
SVA @ Yahoo Finance | SVA Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $2.21 | $2.23 | $0.01 | 0.45% | 0.00 | $2.20 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $2.18 | $2.16 | 113,521 | 120.76M | 216,954 | -9.21 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 2.27 | 2.24 | 2.20 | 2.17 | 2.13 |
Stock Profile
Sinovac Biotech, Ltd. engages in the research, development, commercialization, and sale of human-use vaccines and related products for infectious diseases. It offers Healive, a vaccine for hepatitis A; Bilive, a combined vaccine for hepatitis A and B; and Anflu, a split flu vaccine. The company is also developing SARS vaccine, which is in phase I clinical trails, as well as has a co development agreement with the China Centre of Disease Control and Prevention for the development of Avian Flu-Pandemic Influenza Vaccine. Sinovac Biotech was founded in 1999 and is headquartered in Beijing, China.